Table 1 Participant characteristics in PD patients with different numbers of MH

From: Association of the number of minor hallucinations and well-structured visual hallucinations in Parkinson’s disease

 

No. of MH

 

0

1

2

3

p value

Participants, n (%)

258 (69.35)

66 (17.74)

32 (8.60)

16 (4.30)

 

VH, n (%)

30 (11.63)

7 (10.61)

10 (31.25)

8 (50.00)

<0.001

Age, y, mean (SD)

66.54 (9.91)

67.73 (8.12)

68.16 (9.72)

67.19 (8.13)

0.705

Sex, n (%)

    

0.671

 Male

116 (44.96)

30 (45.45)

12 (37.50)

9 (56.25)

 

 Female

142 (55.04)

36 (54.55)

20 (62.50)

7 (43.75)

 

Education, n (%)

    

0.749

 Illiterate

39 (15.12)

9 (13.64)

1 (4.55)

2 (6.25)

 

 Primary school

40 (15.50)

9 (13.64)

6 (27.27)

9 (28.13)

 

 Middle school

126 (48.84)

36 (54.55)

10 (45.45)

14 (43.75)

 

 College or above

126 (48.84)

12 (18.18)

5 (22.73)

7 (21.88)

 

BMI, mean (SD)

23.93 (3.65)

22.98 (2.94)

23.90 (3.89)

23.35 (3.35)

0.259

Allergies, n (%)

34 (13.18)

8 (12.12)

5 (15.63)

1 (6.25)

0.827

Smoker, n (%)

65 (25.19)

16 (24.24)

9 (28.13)

2 (12.50)

0.677

Alcohol intake, n (%)

35 (13.57)

12 (18.18)

8 (25.00)

1 (6.25)

0.222

Daily exercise, n (%)

130 (50.39)

34 (51.52)

14 (43.75)

6 (37.50)

0.704

Hypertension, n (%)

101 (39.15)

19 (28.79)

15 (46.88)

9 (56.25)

0.125

Diabetes, n (%)

28 (10.85)

12 (18.18)

3 (9.38)

1 (6.25)

0.327

Family history of PD, n (%)

26 (10.08)

4 (6.06)

4 (12.50)

3 (18.75)

0.434

Age of onset, y, mean (SD)

60.75 (10.56)

61.47 (9.96)

60.78 (10.24)

59.88 (8.98)

0.939

Disease duration, y, mean (SD)

5.83 (4.86)

6.35 (4.92)

7.56 (4.68)

7.09 (3.17)

0.200

LEDD, mg, mean (SD)

450.42 (385.20)

450.85 (344.50)

615.92 (304.18)

547.55 (411.21)

0.093

UPDRS III, mean (SD)

33.52 (15.65)

31.23 (17.76)

36.53 (16.01)

30.56 (7.24)

0.395

H-Y stage, mean (SD)

2.48 (0.82)

2.52 (0.70)

2.66 (0.57)

2.38 (0.47)

0.602

  1. Categorical variables are presented as n (percentage, %), continuous variables are presented as mean (standard deviation, SD). Group comparisons were performed using chi-square test or analyses of variance as appropriate.
  2. PD Parkinson’s disease, MH minor hallucinations, VH visual hallucinations, SD standard deviation, BMI body mass index, LEDD levodopa equivalent daily dose, UPDRS Unified Parkinson’s Disease Rating Scale, H-Y Hoehn and Yahr.
  3. Bold value indicates statistical significance at a two-tailed p value of 0.05.